Free shipping on all orders over $ 500

Satavaptan

Cat. No. M25409

All AbMole products are for research use only, cannot be used for human consumption.

Satavaptan Structure
Synonym:

SR121463

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Satavaptan (SR 121463) is a vasopressin V2 receptor antagonist. Satavaptan improves the control of ascites in cirrhosis. Satavaptan blocks dDAVP-mediated activation of basophilic kinases, while also blocking dDAVP-mediated inhibition of proline-directed kinases. Satavaptan affects a variety of dDAVP-mediated processes including regulation of cell-cell junctions, actin cytoskeleton dynamics, and signaling through Rho GTPases.

Chemical Information
Molecular Weight 643.79
Formula C33H45N3O8S
CAS Number 185913-78-4
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jennifer Ji Young Lee, et al. CMAJ. Management of hyponatremia

[2] Florence Wong, et al. Gut. Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity

[3] Pere Ginès, et al. Hepatology. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial

Related Vasopressin Receptor Products
Mozavaptan

Mozavaptan (OPC-31260) is a benzazepine derivative and a potent, selective, competitive and orally active vasopressin V2 receptor antagonist with an IC50 of 14 nM. Mozavaptan shows ~85-fold selectivity for V2 receptor over V1 receptor (IC50 of 1.2 μM), and can antagonize the antidiuretic action of arginine vasopressin (AVP) in vivo.

Tolvaptan

Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation.

Conivaptan hydrochloride

Conivaptan hydrochloride is a non-peptide vasopressin receptor antagonist, which can inhibit V1A receptor in rat liver and V2 receptor in kidney with Ki values of 0.48 and 3.04 nM, respectively.

Atosiban Acetate

Atosiban (RW22164; Tractocile) Acetate is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane.

L-371,257

L-371,257 is a potent and selective oxytocin receptor antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: Satavaptan, SR121463 supplier, Vasopressin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.